62,599 Shares in Cigna Group $CI Acquired by Nykredit A S

Nykredit A S bought a new stake in shares of Cigna Group (NYSE:CI) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 62,599 shares of the health services provider’s stock, valued at approximately $17,257,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Wilkerson Advisory Group LLC purchased a new stake in shares of Cigna Group during the 4th quarter valued at about $25,000. Osbon Capital Management LLC bought a new stake in Cigna Group during the second quarter valued at approximately $26,000. Kemnay Advisory Services Inc. bought a new stake in Cigna Group during the fourth quarter valued at approximately $29,000. Prosperity Bancshares Inc purchased a new stake in Cigna Group during the fourth quarter valued at approximately $29,000. Finally, Cedar Mountain Advisors LLC raised its position in Cigna Group by 161.9% in the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after acquiring an additional 68 shares during the period. 86.99% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on CI. Sanford C. Bernstein lifted their price target on shares of Cigna Group from $371.00 to $381.00 and gave the stock an “outperform” rating in a research note on Thursday, July 9th. Mizuho raised their target price on Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Jefferies Financial Group downgraded Cigna Group from a “buy” rating to a “hold” rating and lowered their target price for the company from $336.00 to $307.00 in a research report on Tuesday, August 4th. Robert W. Baird set a $362.00 price target on Cigna Group in a report on Friday, July 31st. Finally, Piper Sandler reduced their price target on Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a research report on Wednesday, June 3rd. Fifteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $339.45.

Cigna Group Trading Down 1.4%

Shares of Cigna Group stock opened at $282.24 on Friday. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The company has a market capitalization of $74.58 billion, a P/E ratio of 11.68, a P/E/G ratio of 0.98 and a beta of 0.31. The company has a fifty day moving average of $283.51 and a 200 day moving average of $281.07.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. The business had revenue of $70.04 billion for the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The business’s quarterly revenue was up 6.7% on a year-over-year basis. During the same period last year, the firm earned $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, sell-side analysts anticipate that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a $1.56 dividend. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s payout ratio is currently 25.82%.

Insider Activity at Cigna Group

In other news, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the transaction, the chief accounting officer owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Nicole S. Jones sold 19,436 shares of the company’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the transaction, the insider owned 27,256 shares of the company’s stock, valued at approximately $7,530,015.12. This represents a 41.63% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 23,012 shares of company stock valued at $6,386,550 over the last 90 days. 0.60% of the stock is currently owned by corporate insiders.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.